Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01924182 · ClinicalTrials.gov registry record · NA
Intrathecal Morphine Compared to Conventional Medical Management for Pain Control and Opioid-related Side Effects
A NA study, sponsored by MedtronicNeuro.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT01924182 is a NA study that was terminated before completion, run by MedtronicNeuro. The registered enrollment target is 7 participants.
The verdict
NCT01924182, a NA study, was terminated before completion, sponsored by MedtronicNeuro.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This study compares two different ways to treat pain. The two ways are: 1. continuing to take current pain medication(s) or 2. receiving morphine, a pain medication from a drug pump (a system to deliver drug to your body) that is implanted. None of the procedures or products used in this study are experimental. The length the study will be about 25 weeks (between 5½ to 6½ months). The purpose of this study is to compare pain and opioid side effects between people who get a drug pump and people who do not get a drug pump that will stay on their current pain medication treatment.
Interventions
- DEVICE SynchroMed Infusion System and Intrathecal Morphine Sulfate
- OTHER Conventional Medicine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2013-10 |
| Est. Completion | 2015-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01924182
The ClinicalTrials.gov registry entry for NCT01924182 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedtronicNeuro, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SynchroMed Infusion System and Intrathecal Morphine Sulfate is the first listed.
NCT01924182 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01924182 about?
NCT01924182 is a clinical study titled "Intrathecal Morphine Compared to Conventional Medical Management for Pain Control and Opioid-related Side Effects". This study compares two different ways to treat pain. The two ways are: 1. continuing to take current pain medication(s) or 2. receiving morphine, a pain medication from a drug pump (a system to deliver drug to your body) that is implanted. None of the procedures or products used in this study are...
What is the current status of trial NCT01924182?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2013-10. Estimated completion is 2015-07.
What interventions are being tested in trial NCT01924182?
The interventions under investigation include: SynchroMed Infusion System and Intrathecal Morphine Sulfate (DEVICE), Conventional Medicine (OTHER).
Who is sponsoring clinical trial NCT01924182?
This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.